Dr. Forester is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
115 Mill St
Belmont, MA 02478Phone+1 617-855-3622
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Geriatric Psychiatry, 1996 - 1997
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1992 - 1996
- Geisel School of Medicine at DartmouthClass of 1992
Certifications & Licensure
- NH State Medical License 1996 - 2026
- MA State Medical License 1994 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
- Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression Start of enrollment: 2018 May 29
Publications & Presentations
PubMed
- 47 citationsEfficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.Taeho Greg Rhee, Sung Ryul Shim, Brent P Forester, Andrew A Nierenberg, Roger S McIntyre
JAMA Psychiatry. 2022-12-01 - 169 citationsImpact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.John F. Greden, Sagar V. Parikh, Anthony J. Rothschild, Michael E. Thase, Boadie W. Dunlop
Journal of Psychiatric Research. 2019-04-01 - 22 citationsReport on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-...Brent P. Forester, Mark Vanelli, Joan Hyde, Rosa Perez, Calixte Ahokpossi
The American Journal of Geriatric Pharmacotherapy. 2007-09-01
Press Mentions
- Cannabis Product May Help Ease Agitation of Alzheimer’sOctober 9th, 2024
- Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s DiseaseOctober 2nd, 2024
- Dronabinol Shows Promise in Reducing Agitation in Alzheimer's PatientsOctober 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: